Patents by Inventor Jeffrey Ecsedy

Jeffrey Ecsedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240254120
    Abstract: The present invention provides N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide compositions, and the use thereof for treating a proliferative disorder.
    Type: Application
    Filed: December 13, 2023
    Publication date: August 1, 2024
    Inventors: Mark MANFREDI, Jeffrey Ecsedy, Alfredo C. Castro, Yoshiyuki Okumura
  • Publication number: 20240066040
    Abstract: The present invention provides use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for treatment of a cancer.
    Type: Application
    Filed: July 19, 2023
    Publication date: February 29, 2024
    Inventors: Mark MANFREDI, Jeffrey Ecsedy, Atsushi Nagahisa, Yukinori Take, Takako Okumura
  • Patent number: 10973834
    Abstract: The present invention provides use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for treatment of a cancer.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: April 13, 2021
    Assignees: Arrys Therapeutics, Inc., AskAt Inc.
    Inventors: Mark Manfredi, Jeffrey Ecsedy, Atsushi Nagahisa, Yukinori Take, Takako Okumura
  • Publication number: 20190314390
    Abstract: The present invention provides use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for treatment of a cancer.
    Type: Application
    Filed: April 16, 2019
    Publication date: October 17, 2019
    Inventors: Mark Manfredi, Jeffrey Ecsedy, Atsushi Nagahisa, Yukinori Take, Takako Okumura